Depression and the metabolic syndrome in middle-aged women: A longitudinal investigation
by Goldbacher, Edie Marie, Ph.D., UNIVERSITY OF PITTSBURGH, 2007, 121 pages; 3284565

Abstract:

Depression predicts increased risk of coronary artery disease and type 2 diabetes, and the metabolic syndrome (MS) is a putative link between depression and these diseases. There are no prospective studies of the effect of major depression on risk for the MS. This study examined the cross-sectional and longitudinal relationship of major depression with the MS, central adiposity, and insulin resistance (IR), over a period of 6 years. Data were drawn from the “Study of Women’s Health Across the Nation”, an ongoing, multi-site investigation of perimenopausal women. The sample included 421 women (34% Black), ages 42-52 (M = 45.6 + 2.5) from the ancillary Mental Health Study of the participants from the Pittsburgh site. Major depression diagnosis (lifetime history and current), other diagnoses (anxiety disorders, substance abuse/dependence) and antidepressant use were collected annually via the SCID-IV. The MS was measured at baseline and bi-annually thereafter; WC and IR were assessed annually. Health behaviors included smoking (annually), and physical activity and diet (baseline). Logistic regression and survival analyses examined the odds/risk of developing the MS over the course of the study in the full sample and in women free of the MS at baseline. Generalized Estimating Equations (GEE) examined the relationship between depression (time-varying) and the MS (time-varying) over the course of the study. Exploratory analyses were conducted to examine whether associations were independent of demographics, diabetes, and other diagnoses, and to examine the association of depression with WC. Baseline depression predicted marginally greater odds of having the MS over the course of the study (cumulative index) in the full sample, independent of covariates. Women with baseline depression showed a trend for increased risk of developing the MS; this effect was not significant. GEE analyses showed no significant concurrent associations between depression and the MS across time, suggesting that depression and the MS did not “track” together over time. Finally, baseline depression predicted greater WC at the final visit, although this was reduced after controlling for age and race. Findings suggest that major depression may be an important predictor of the prevalence and incidence of the MS in women.

 
Advisor
SchoolUNIVERSITY OF PITTSBURGH
SourceDAI/B 68-09, p. , Dec 2007
Source TypeDissertation
SubjectsWomen's studies; Clinical psychology; Physiological psychology
Publication Number3284565
Adobe PDF Access the complete dissertation:
 

» Find an electronic copy at your library.
  Use the link below to access a full citation record of this graduate work:
  http://gateway.proquest.com/openurl%3furl_ver=Z39.88-2004%26res_dat=xri:pqdiss%26rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation%26rft_dat=xri:pqdiss:3284565
  If your library subscribes to the ProQuest Dissertations & Theses (PQDT) database, you may be entitled to a free electronic version of this graduate work. If not, you will have the option to purchase one, and access a 24 page preview for free (if available).

About ProQuest Dissertations & Theses
With over 2.3 million records, the ProQuest Dissertations & Theses (PQDT) database is the most comprehensive collection of dissertations and theses in the world. It is the database of record for graduate research.

The database includes citations of graduate works ranging from the first U.S. dissertation, accepted in 1861, to those accepted as recently as last semester. Of the 2.3 million graduate works included in the database, ProQuest offers more than 1.9 million in full text formats. Of those, over 860,000 are available in PDF format. More than 60,000 dissertations and theses are added to the database each year.

If you have questions, please feel free to visit the ProQuest Web site - http://www.proquest.com - or call ProQuest Hotline Customer Support at 1-800-521-3042.